A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10292757" target="_blank" >RIV/00064203:_____/14:10292757 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/14:10292757
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.ejogrb.2013.12.021" target="_blank" >http://dx.doi.org/10.1016/j.ejogrb.2013.12.021</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejogrb.2013.12.021" target="_blank" >10.1016/j.ejogrb.2013.12.021</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy
Popis výsledku v původním jazyce
Objectives: To monitor fetal anemia during administration of chemotherapy to the fetus's mother. Study design: Between 2007 and 2012 six patients with malignancy diagnosed during pregnancy were included in our prospective study. For evaluation of fetal anemia, peak systolic velocimetry (PSV) of the middle cerebral artery is considered the best method. The patients were repeatedly examined one day before and on the third day after the administration of chemotherapy. At least three measurements were performed and the highest value was used as appropriate. Multiples of the median (MoM) were calculated using the website http://www.perinatology.com/calculators/MCA.htm. When the MoM reached 1.29, moderate anemia was diagnosed. Results: The women's average age was 30 years. The average gestational age at diagnosis was 20.7 weeks of pregnancy. Borderline fetal anemia was detected in only in one patient. After delivery newborns were examined by standard pediatric evaluation and blood count was
Název v anglickém jazyce
A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy
Popis výsledku anglicky
Objectives: To monitor fetal anemia during administration of chemotherapy to the fetus's mother. Study design: Between 2007 and 2012 six patients with malignancy diagnosed during pregnancy were included in our prospective study. For evaluation of fetal anemia, peak systolic velocimetry (PSV) of the middle cerebral artery is considered the best method. The patients were repeatedly examined one day before and on the third day after the administration of chemotherapy. At least three measurements were performed and the highest value was used as appropriate. Multiples of the median (MoM) were calculated using the website http://www.perinatology.com/calculators/MCA.htm. When the MoM reached 1.29, moderate anemia was diagnosed. Results: The women's average age was 30 years. The average gestational age at diagnosis was 20.7 weeks of pregnancy. Borderline fetal anemia was detected in only in one patient. After delivery newborns were examined by standard pediatric evaluation and blood count was
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FK - Gynekologie a porodnictví
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Journal of Obstetrics, Gynecology and Reproductive Biology
ISSN
0301-2115
e-ISSN
—
Svazek periodika
174
Číslo periodika v rámci svazku
neuveden
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
4
Strana od-do
76-79
Kód UT WoS článku
000333505500013
EID výsledku v databázi Scopus
—